Ruder Finn London has been handed the 12-month brief following a competitive pitch against three undisclosed agencies. The as-yet-unnamed product has been submitted for license for the treatment of opioid induced constipation in patients receiving palliative care.
Ruder Finn has been tasked with driving a strategic comms programme to pave the way for the product’s launch in the UK at the end of 2008. The agency will handle pre-license and launch comms activities.
The Ruder Finn team will be headed up by associate director Jaimie Brown.